Diltiazem Hydrochloride - manufacturers, supply & price · Pillstats

Who makes it31 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

Labeler	Type	Packages	Status
SUN PHARMACEUTICAL INDUSTRIES, INC.	generic	65	SUPPLYING
Zydus Lifesciences Limited	generic	55	SUPPLYING
Zydus Pharmaceuticals USA Inc.	generic	55	SUPPLYING
Alembic Pharmaceuticals Limited	generic	48	SUPPLYING
Bryant Ranch Prepack	repackager	40	SUPPLYING
Ingenus Pharmaceuticals, LLC	unknown	26	SUPPLYING
Upsher-Smith Laboratories, LLC	unknown	21	SUPPLYING
Macleods Pharmaceuticals Limited	generic	15	SUPPLYING
Bausch Health US, LLC	unknown	12	SUPPLYING
A-S Medication Solutions	repackager	10	SUPPLYING
Oceanside Pharmaceuticals	unknown	10	SUPPLYING
Actavis Pharma, Inc.	generic	9	SUPPLYING
NorthStar Rx LLC	relabeler	9	SUPPLYING
Accord Healthcare Inc.	generic	6	SUPPLYING
Slate Run Pharmaceuticals, LLC	unknown	6	SUPPLYING

+ 16 more labelers

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

Mar 13, 2025
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules 12HR 120mg, 100-count bottle, Rx, Only. Manufactured by: Glenmark Pha…
CGMP Deviations — Recalling firm: Glenmark Pharmaceuticals Inc., USA — U.S. Nationwide
Nov 1, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd…
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA
Nov 1, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 90mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd …
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA
Nov 1, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Rx Only, 100 Capsules, Manufactured for: Glenmark Pharma…
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA
Nov 1, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 90 mg, Rx Only, 100 Capsules, Manufactured for : Glenmark Pharma…
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA
Nov 1, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 60 mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Man…
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA
Nov 1, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 120mg, Twice-a-Day Dosage, Rx Only, 100 Capsules per bottle, Mfd…
cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA
Apr 17, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Ma…
Failed Dissolution Specifications — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the USA.
Mar 26, 2024
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP 120 mg, Twice-a-Day Dosage, 100 Capsules per bottle, Rx Only, Ma…
Failed Dissolution Specifications: Out of Specification (OOS) was reported in test of dissolution at the 12th month time point in long term stability study. — Recalling firm: Glenmark Pharmaceuticals Inc., USA — Nationwide in the US
Jan 13, 2023
RECALLRecall (Class II): Diltiazem Hydrochloride Extended-Release Capsules, USP, 360 mg; Rx only; 90-count bottles, Manufactured by: Sun Pharmac…
Failed Impurity (Deacetyl Diltiazem Hydrochloride) specification during stability testing and failed dissolution testing at FDA laboratory. — Recalling firm: SUN PHARMACEUTICAL INDUSTRIES INC — Nationwide in the U.S.
Oct 27, 2021
RECALLRecall (Class II): Cartia XT (Diltiazem Hydrochloride Extended-Release Capsules, USP) 120 mg, Rx Only, 90 capsules, labelled as (a) Manufa…
Labelling: Incorrect Exp. Date — Recalling firm: Teva Pharmaceuticals USA — Distributed Nationwide in the USA

Diltiazem Hydrochloride

US acquisition costNADAC · per unit

Medicaid dispensing volumeSDUD · per quarter

Who makes it31 active · 0 exited

Regulatory & supply eventsFDA · US